Paperpal Prime Logo

Prostate Cancer and Prostatic Diseases : Impact Factor & More

eISSN: 1476-5608pISSN: 1365-7852

Key Metrics

CiteScore
7.8
H-Index
74
Impact Factor
< 5
SJR
Q1Urology
SNIP
1.72
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Prostate Cancer and Prostatic Diseases

Prostate Cancer and Prostatic Diseases Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher SPRINGERNATURE
Language English
Frequency Quarterly
General Details
LanguageEnglish
FrequencyQuarterly
Publication Start Year1997
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Prostate Cancer and Prostatic Diseases ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Prostate Cancer and Prostatic Diseases

From fungus fighter to cancer slayer: itraconazole as a multifaceted candidate for drug-resistant prostate cancer.
  • 6 Aug 2026
  • Prostate cancer and prostatic diseases
Clinical and genomic determinants of extraordinary response and resistance to androgen receptor pathway inhibitors in men with metastatic androgen pathway modulator sensitive (APMS) prostate cancer.
  • 5 Aug 2026
  • Prostate cancer and prostatic diseases
Germline genetic risk and prostate cancer-specific mortality in a population-based incident cohort.
  • 4 Aug 2026
  • Prostate cancer and prostatic diseases
Prognostic value of cribriform pattern and intraductal carcinoma of the prostate after radical prostatectomy: A systematic review and meta-analysis using contemporary consensus recommendations.
  • 3 Aug 2026
  • Prostate cancer and prostatic diseases
Counseling is counseling is counseling is counseling - The evolution of LUTS/BPO care.
  • 3 Aug 2026
  • Prostate cancer and prostatic diseases
Long-term oncologic outcomes of patients with grade group 1 prostate cancer and pT3a disease on final pathology.
  • 17 Jul 2026
  • Prostate cancer and prostatic diseases
From fungus fighter to cancer slayer: itraconazole as a multifaceted candidate for drug-resistant prostate cancer.
  • 6 Aug 2026
  • Prostate cancer and prostatic diseases
Clinical and genomic determinants of extraordinary response and resistance to androgen receptor pathway inhibitors in men with metastatic androgen pathway modulator sensitive (APMS) prostate cancer.
  • 5 Aug 2026
  • Prostate cancer and prostatic diseases
Germline genetic risk and prostate cancer-specific mortality in a population-based incident cohort.
  • 4 Aug 2026
  • Prostate cancer and prostatic diseases
Prognostic value of cribriform pattern and intraductal carcinoma of the prostate after radical prostatectomy: A systematic review and meta-analysis using contemporary consensus recommendations.
  • 3 Aug 2026
  • Prostate cancer and prostatic diseases
Counseling is counseling is counseling is counseling - The evolution of LUTS/BPO care.
  • 3 Aug 2026
  • Prostate cancer and prostatic diseases
Long-term oncologic outcomes of patients with grade group 1 prostate cancer and pT3a disease on final pathology.
  • 17 Jul 2026
  • Prostate cancer and prostatic diseases

FAQs on Prostate Cancer and Prostatic Diseases